The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| Arcus Biosciences Inc | COM | 03969F109 | 40,850 | 1,612,077 | SH | SOLE | 1,612,077 | 0 | 0 | ||
| Coupang Inc | CL A | 22266T109 | 38,844 | 3,046,571 | SH | SOLE | 3,046,571 | 0 | 0 | ||
| IONQ Inc | COM | 46222L108 | 4,380 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| Novocure Ltd | ORD SHS | G6674U108 | 24,386 | 350,884 | SH | SOLE | 350,884 | 0 | 0 | ||
| Nu Hldgs Ltd | ORD SHS CL A | G6683N103 | 20,880 | 5,582,950 | SH | SOLE | 5,582,950 | 0 | 0 | ||
| Oric Pharmaceuticals Inc | COM | 68622P109 | 4,514 | 1,007,575 | SH | SOLE | 1,007,575 | 0 | 0 | ||
| Oyster Point Pharma Inc | COM | 69242L106 | 11,988 | 2,768,586 | SH | SOLE | 2,768,586 | 0 | 0 | ||
| Taboola.com Ltd | ORD SHS | M8744T106 | 19,784 | 7,819,690 | SH | SOLE | 7,819,690 | 0 | 0 | ||